197 Grants*
The grant details show the name of the PI, active dates of the project, the immediate and prime sponsor and the abstract of the grant. If a abstract and title are used to create the Fingerprint of the grant. The source of grants for this application comes from authorized users entering data, so only grants entered into the system by researchers or authorized users appear in this application.
-
1.
Talya Salz
Toward Risk-stratified care for lymphoma survivors
Leukemia and Lymphoma Society
Funding: $ 523,810
-
2.
Kathryn Anderson
Isolation of Novel Mutations Affecting the Mouse Embryo
National Institute of Child Health and Human Development
Funding: $ 2,008,850
-
3.
Xuejun Jiang
Autophagy and TGFb Antagonist-Signaling in Breast Cancer Dormancy at Pre-Metastatic Sites
United States Army Medical Research Acquisition Activity
Funding: $ 187,500
-
4.
Filippo Giancotti
Autophagy and TGF-Beta Antagonist-Signaling in Breast Cancer Dormancy at Pre-Metastatic Sites
United States Army Medical Research Acquisition Activity
Funding: $ 187,499
-
5.
Richard Kolesnick
Re-setting the Endothelial Ceramide Rheostat
National Cancer Institute
Funding: $ 923,375
-
6.
Richard O'Reilly
The Immunobiology of Marrow Allografts for Leukemia
National Cancer Institute
Funding: $ 7,497,546
-
7.
Craig Thompson
Role of IDH Mutations in Acute Myeloid Malignancies
National Cancer Institute
Funding: $ 985,625
-
8.
Filippo Giancotti
Mechanisms governing metastatic reactivation of breast cancer.
National Cancer Institute
Funding: $ 1,183,862
-
9.
Ronald Blasberg
Imaging and Targeting Metastatic-Prone Breast Cancer
National Cancer Institute
Funding: $ 1,560,096
-
10.
Lorenz Studer
Developing a human ES cell derived dopamine neuron source for cell therapy in Parkinson's disease
NYSTEM Program of New York State Department of Health
Funding: $ 13,043,115
-
11.
Suzanne Wolden
Radiation Oncology Review: NIH COG Chair Grant
Children's Hospital of Philadelphia
Sponsor: Children's Oncology Group
Funding: $ 6,467
-
12.
Mark Ptashne
NYSTEM Program of New York State Department of Health
Funding: $ 870,263
-
13.
Eric Lai
Control of neural stem cell identity by the zinc finger protein Ars2
NYSTEM Program of New York State Department of Health
Funding: $ 882,198
-
14.
Ross Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
National Cancer Institute
Funding: $ 2,375,521
-
15.
Colin Begg
Identification of Etiologically Distinct Sub-Types of Breast Cancer
National Cancer Institute
Funding: $ 206,625
-
16.
Xuejun Jiang
Mechanisms and Function of Autophagy in Cancer
National Cancer Institute
Funding: $ 985,625
-
17.
Kathleen Foley
International Palliative Care Initiative Directorship
Open Society Institute
Funding: $ 800,000
-
18.
Gary Schwartz
Therapeutic Targeting of IDH1 and IDH2 Mutations in Acute Myeloid Leukemia (AML) and Chondrosarcoma
Starr Cancer Consortium
Funding: $ 249,778
-
19.
Ross Levine
Discovery of AID-dependent Epigenetic Mechanisms in Hematological Malignancies
Starr Cancer Consortium
Funding: $ 166,666
-
20.
Ross Levine
Therapeutic Targeting of IDH1 and IDH2 Mutations in Acute Myeloid Leukemia (AML) and Chondrosarcoma
Starr Cancer Consortium
Funding: $ 249,778
-
21.
Cameron Brennan
Elucidating Mechanisms of Histone H3.3 Mutants-Mediated Oncogenesis in Pediatric Brain Cancers
Starr Cancer Consortium
Funding: $ 70,000
-
22.
Viviane Tabar
Elucidating Mechanisms of Histone H3.3 Mutants-Mediated Oncogenesis in Pediatric Brain Cancers
Starr Cancer Consortium
Funding: $ 172,000
-
23.
James Fagin
Molecular Pathophysiology of Thyroid Cell Growth
National Cancer Institute
Funding: $ 1,057,684
-
24.
Wendy Lichtenthal; William Breitbart
Pilot Study of a Meaning-Centered Group for Breast Cancer Survivors
American Cancer Society
Funding: $ 384,424
-
25.
Bhuvanesh Singh; Ronald Ghossein
SAIC-Frederick
Sponsor: National Cancer Institute
Funding: $ 26,445
-
26.
Neal Rosen
DFCI Pediatric Low-Grade Astrocytoma Program
Dana Farber Cancer Institute
Sponsor: Other
Funding: $ 122,727
-
27.
Ross Levine
Targeting cytosine hydroxymethylation in AML stem cells
Leukemia and Lymphoma Society
Funding: $ 540,054
-
28.
Nai-Kong Cheung
Congressionally Directed Medical Research Programs
Funding: $ 1,477,221
-
29.
Ross Levine
Enhancing Targeted Therapy for Myeloproliferative Neoplasms
H. Lee Moffitt Cancer Center & Research Institute
Sponsor: Congressionally Directed Medical Research Programs
Funding: $ 53,704
-
30.
Ingo Mellinghoff
Molecular Mechanisms of IDH1-mediated Gliomagenesis
National Institute of Neurological Disorders and Stroke
Funding: $ 1,185,758
-
31.
Kenneth Offit
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
Weill Medical College of Cornell University
Sponsor: National Cancer Institute
Funding: $ 283,966
-
32.
Clifford Hudis
Breast microcalcifications and their role in breast cancer bone metastasis
Cornell University
Sponsor: National Cancer Institute
Funding: $ 208,461
-
33.
Clifford Hudis; Ayca Gucalp
MD Anderson Cancer Center
Sponsor: National Cancer Institute
Funding: $ 278,613
-
34.
Clifford Hudis
Weill Medical College of Cornell University
Sponsor: National Cancer Institute
Funding: $ 52,084
-
35.
Jonine Bernstein
Mammographic Density and Risk of Contralateral Breast Cancer
National Cancer Institute
Funding: $ 1,492,868
-
36.
Katharine Hsu
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
Food and Drug Administration
Funding: $ 331,303
-
37.
Mark Kris
Targets for Therapy for Carcinomas of the Lung
National Cancer Institute
Funding: $ 5,678,335
-
38.
Jamie Ostroff
Integrating Tobacco Treatment Into Cancer Care
Massachusetts General Hospital
Sponsor: National Cancer Institute
Funding: $ 705,870
-
39.
Eric Lai
Non-canonical miRNA biogenesis mechanisms in Drosophila and mammals
National Institute of General Medical Sciences
Funding: $ 1,053,281
-
40.
Katharine Hsu
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
National Cancer Institute
Funding: $ 602,761
-
41.
Alexander Rudensky
Self Peptides Bound to MHC Class II In T Cell Selection
National Institute of Allergy and Infectious Diseases
Funding: $ 1,208,073
-
42.
Jamie Ostroff
Psychosocial Palliative and Community Research in Cancer
National Cancer Institute
Funding: $ 2,205,088
-
43.
Timothy Chan
The mutational landscapes underlying aggressiveness in adenoid cystic carcinoma
National Institute of Dental and Craniofacial Research
Funding: $ 275,000
-
44.
Jennifer Hay
Measuring real time decision-making about UVR Protection
National Cancer Institute
Funding: $ 242,000
-
45.
Moritz Kircher
National Cancer Institute
Funding: $ 827,500
-
46.
-
47.
Scott Lowe
Roles and Regulation of p53 - Core C
Columbia University
Sponsor: National Cancer Institute
Funding: $ 225,524
-
48.
Scott Lowe
Roles and Regulation of p53 - Project 3
Columbia University
Sponsor: National Cancer Institute
Funding: $ 1,022,013
-
49.
Richard Kolesnick
NEUTRALIZATION OF CERAMIDE AS A NOVEL APPROACH TO SPECIFICALLY INHIBIT ACUTE GVHD
Ceramide Therapeutics, LLC
Sponsor: National Institute of Allergy and Infectious Diseases
Funding: $ 93,976
-
50.
Mark Kris
Lung Cancer Mutation Consortium (LCMC)
National Lung Cancer Partnership
Sponsor: University of Colorado at Denver
Funding: $ 75,000
-
51.
Marcel Van Den Brink
Mucosal Immunity and Microbiota in Intestinal Graft-versus-Host Disease
National Institute of Allergy and Infectious Diseases
Funding: $ 1,125,000
-
52.
Danwei Huangfu
Understanding pancreatic progenitors for diabetes cell-replacement therapy
National Institute of Diabetes & Digestive & Kidney Diseases
Funding: $ 1,087,500
-
53.
Pat Zanzonico
The Inveon PET/CT for Pre-Clinical Oncology Research
National Institutes of Health - Office of the Director
Funding: $ 1,027,842
-
54.
Kathryn Anderson
Genetic Analysis of Mouse Nervous System Development
National Institute of Neurological Disorders and Stroke
Funding: $ 1,597,975
-
55.
Kathryn Anderson
Isolation of Novel Mutations Affecting the Mouse Embryo
National Institute of Child Health and Human Development
Funding: $ 1,805,744
-
56.
Ross Levine
Molecular Pathogenesis and Therapy of Myeloproliferative Neoplasms
Leukemia and Lymphoma Society
Funding: $ 523,810
-
57.
Ming Li
The Adrb-cAMP-ICER Pathway in Control of Mammary Tumor Immune Evasion
Cancer Research Institute
Funding: $ 200,000
-
58.
Ross Levine
Role of TET2 IDH mutations in pathogenesis and therapy of AML acute myeloid
Samuel Waxman Cancer Research Foundation
Funding: $ 100,000
-
59.
Lisa De Angelis
A Pilot Trial of Enoxaprin vs. Aspirin in Patients with Cancer and Stroke
Clinical and Translational Science Center
Sponsor: National Center for Research Resources
Funding: $ 11,520
-
60.
Katharine Hsu
Hematopoeitic Stem Cell Transplantation
Fred Hutchinson Cancer Research Center
Sponsor: National Institute of Allergy and Infectious Diseases
Funding: $ 121,209
-
61.
Lorenz Studer
McLean Hospital
Sponsor: National Institute of Neurological Disorders and Stroke
Funding: $ 199,714
-
62.
Ross Levine
Evaluation of the Pathobiology of ET & PV in Pediatric Patients
Weill Medical College of Cornell University
Sponsor: Clinical and Translational Science Center
Funding: $ 21,600
-
63.
Clifford Hudis
(Komen): Translational Breast Cancer Research Consortium Infrastructure Support Task Order
Johns Hopkins University
Sponsor: Susan G. Komen Breast Cancer Foundation
Funding: $ 221,500
-
64.
Marcel Van Den Brink
National Institute of Allergy and Infectious Diseases
Funding: $ 1,357,685
-
65.
Ronald Blasberg
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
National Cancer Institute
Funding: $ 1,230,565
-
66.
Charles Sawyers
Understanding Resistance to Next Generation Antiandrogens
National Cancer Institute
Funding: $ 1,047,107
-
67.
Ross Levine
Investigation of the effects of Asxl1 loss on hematopoietic stem cell self-renewal
American Society of Hematology
Funding: $ 5,000
-
68.
Kathryn Anderson
Tissue-specific Roles of Axin in Canonical Wnt Signaling and Tumorigenesis
National Cancer Institute
Funding: $ 179,438
-
69.
Ira Dunkel
Pediatric Brain Tumor Consortium (PBTC)
Saint Jude Children's Research Hospital
Sponsor: National Cancer Institute
Funding: $ 51,413
-
70.
Hedvig Hricak
Subcontract to anonymize and transfer radiological imaging data for The Cancer Imaging ARchive
SAIC-Frederick
Sponsor: National Cancer Institute
Funding: $ 25,350
-
71.
Michelle Bradbury
National Cancer Institute
Funding: $ 1,682,975
-
72.
Gabriela Chiosis
Biomarkers of response to Hsp90 inhibitors in triple-negative breast cancer
National Cancer Institute
Funding: $ 179,438
-
73.
Cameron Brennan
EFGR and PTEN in Human and Mouse Glioma
MD Anderson Cancer Center
Sponsor: National Cancer Institute
Funding: $ 55,480
-
74.
-
75.
Johanna Joyce
Interleukins, macrophages and cathepsin proteases in the cancer microenvironment
American Cancer Society
Funding: $ 600,000
-
76.
Ming Li
Transforming Growth Factor-beta1 Control of Tumor Immune Evasion
American Cancer Society
Funding: $ 600,000
-
77.
Anna-Katerina Hadjantonakis
Morphogenesis of the paraxial mesoderm in mice
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Funding: $ 1,258,016
-
78.
Michael Kharas
2012 Louis V. Gerstner Young Investigators Fund Award
Louis V. Gerstner Young Investigators Fund
Funding: $ 225,000
-
79.
Kitai Kim
2012 Louis V. Gerstner Young Investigators Fund Award
Louis V. Gerstner Young Investigators Fund
Funding: $ 225,000
-
80.
Michael Kharas
The role of Musashi-2 in hematopoiesis and leukemia
American Society of Hematology
Funding: $ 137,776
-
81.
Clifford Hudis
(BCRF): The Breast Cancer Clinical Trials Consortium
Johns Hopkins University
Sponsor: Breast Cancer Research Foundation, The
Funding: $ 302,916
-
82.
Clifford Hudis
University of Michigan
Sponsor: Breast Cancer Research Foundation, The
Funding: $ 30,695
-
83.
Joao Xavier
Engineering microbial social interactions: Towards new anti-biofilm therapies
National Institutes of Health - Office of the Director
Funding: $ 1,500,000
-
84.
Alan Hall
Rho GTPases and polarity signaling pathways in morphogenesis and migration
National Institute of General Medical Sciences
Funding: $ 1,480,010
-
85.
Steven Larson
124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer
National Cancer Institute
Funding: $ 415,000
-
86.
Richard O'Reilly
EBV Specific T-cells from 3rd party donors for treatment of EBV-associated malignancies
National Cancer Institute
Funding: $ 415,000
-
87.
Michel Sadelain; Prasad Adusumilli
Congressionally Directed Medical Research Programs
Funding: $ 1,381,580
-
88.
-
89.
Craig Thompson
Cancer Cell Adaptation to Metabolic Stress
University of Pennsylvania
Sponsor: National Cancer Institute
Funding: $ 640,111
-
90.
Andrew Vickers
Fred Hutchinson Cancer Research Center
Sponsor: National Cancer Institute
Funding: $ 55,216
-
91.
Scott Lowe
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
Cold Spring Harbor Laboratory
Sponsor: National Cancer Institute
Funding: $ 377,093
-
92.
Eric Lai
BEN factors are conserved CSL co-repressors in Notch-mediated neural development
National Institute of Neurological Disorders and Stroke
Funding: $ 1,177,727
-
93.
-
94.
Kenneth Offit
Genomewide Discovery of Novel Cancer Predisposing Mutations
Starr Cancer Consortium
Funding: $ 208,138
-
95.
Viviane Tabar
Starr Cancer Consortium
Funding: $ 360,000
-
96.
Scott Lowe
University of Southern California
Sponsor: National Cancer Institute
Funding: $ 365,379
-
97.
Charles Sawyers
Starr Cancer Consortium
Funding: $ 450,000
-
98.
Charles Sawyers
Genome wide profiling of single cells for diagnosis and monitoring in prostate cancer
Starr Cancer Consortium
Funding: $ 105,900
-
99.
Howard Scher
Genome wide profiling of single cells for diagnosis and monitoring in prostate cancer.
Starr Cancer Consortium
Funding: $ 105,900
-
100.
Scott Lowe
Cold Spring Harbor Laboratory Cancer Research Center
Cold Spring Harbor Laboratory
Sponsor: National Cancer Institute
Funding: $ 1,056,045
-
101.
Scott Lowe
Mechanisms of Treatment Responsiveness and Resistance in Myeloid Malignancies/LLS SCOR
Leukemia and Lymphoma Society
Funding: $ 2,581,029
-
102.
Jedd Wolchok
Summer research experiences for medical students supervised by faculty mentors
National Cancer Institute
Funding: $ 1,233,327
-
103.
Ying Taur
Effects of the Intestinal Microbiota on Infections During Bone Marrow Transplant
National Institute of Allergy and Infectious Diseases
Funding: $ 612,013
-
104.
Charles Sawyers
Translational Research in Oncology Training Program
National Cancer Institute
Funding: $ 907,548
-
105.
Lorenz Studer
Research Training Program in Stem Cell Biology
NYSTEM Program of New York State Department of Health
Funding: $ 1,725,000
-
106.
Peter Bach
Radiomics of Lung Cancer Screening
H. Lee Moffitt Cancer Center & Research Institute
Sponsor: Florida Department of Health and the James and Esther King Biomedical Research Program
Funding: $ 43,907
-
107.
Steven Larson; Ronald Blasberg
MSKCC Center for Molecular Imaging in Cancer
National Cancer Institute
Funding: $ 4,359,914
-
108.
Jason Huse
Personalizing PI3K/AKT pathway inhibitor therapy in malignant glioma
American Association for Cancer Research
Funding: $ 100,000
-
109.
Song-Hai Shi
Proliferation, Specification & Brain Function
Weill Medical College of Cornell University
Sponsor: National Institute of Neurological Disorders and Stroke
Funding: $ 956,310
-
110.
Katharine Hsu
Hematopoeitic Stem Cell Transplantation
Fred Hutchinson Cancer Research Center
Sponsor: National Institute of Allergy and Infectious Diseases
Funding: $ 981,437
-
111.
-
112.
Gabriela Chiosis
Targeting the heat shock response for the therapy of DLBCL
Weill Medical College of Cornell University
Sponsor: National Cancer Institute
Funding: $ 513,885
-
113.
Minkui Luo; Hakim Djaballah
Profile substrates and inhibitors of protein lysine methyltransferase
National Institute of General Medical Sciences
Funding: $ 732,710
-
114.
Jamie Ostroff
An Interactive E-Health Program to Promote Health Behaviors among Cancer Survivors
New York University School of Medicine
Sponsor: National Cancer Institute
Funding: $ 73,187
-
115.
Danwei Huangfu
2011 Louis V. Gerstner Young Investigators Fund Award
Louis V. Gerstner Young Investigators Fund
Funding: $ 225,000
-
116.
Clifford Hudis
Johns Hopkins University
Sponsor: Breast Cancer Research Foundation, The
Funding: $ 4,200
-
117.
Nai-Kong Cheung
Engineering and Evaluation of Human L-Methionase for Cancer Therapy
University of Texas at Austin
Sponsor: National Cancer Institute
Funding: $ 245,360
-
118.
-
119.
Anna-Katerina Hadjantonakis
Information processing by signal transduction and gene regulatory networks in mammalian cells
Human Frontier Science Program
Funding: $ 280,000
-
120.
Gabriela Chiosis
HSP70 as a Novel Target to Specifically Ablate and Detect Acute Myelogenous Leukemia Stem Cells
Weill Medical College of Cornell University
Sponsor: Leukemia and Lymphoma Society
Funding: $ 216,021
-
121.
David Scheinberg
TCR-like mAb selective for WT1/MHC complexes for therapy of acute Leukemia
Leukemia and Lymphoma Society
Funding: $ 540,054
-
122.
Renier Brentjens
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T Cells
National Cancer Institute
Funding: $ 1,490,794
-
123.
Lorenz Studer
Cellular dissection of herpes simplex encephalitis with iPS cells
Rockefeller University
Sponsor: National Institute of Neurological Disorders and Stroke
Funding: $ 525,876
-
124.
Peter Bach
Development of disease status coding system for routine oncology care
National Cancer Institute
Funding: $ 48,292
-
125.
Ross Levine
DFCI Consortia on Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
Dana Farber Cancer Institute
Sponsor: National Cancer Institute
Funding: $ 405,200
-
126.
Lorenz Studer
NYSTEM Program of New York State Department of Health
Funding: $ 900,000
-
127.
Lorenz Studer
NYSTEM Program of New York State Department of Health
Funding: $ 900,000
-
128.
Viviane Tabar
Multipotential cancer stem cells in gliomas
NYSTEM Program of New York State Department of Health
Funding: $ 275,000
-
129.
Mark Ptashne
NYSTEM Program of New York State Department of Health
Funding: $ 274,989
-
130.
Ming Li
TGF-beta and Common gamma-chain Cytokine Crosstalk in T Cell Regulation
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding: $ 1,078,200
-
131.
Lee Krug; David Scheinberg
Congressionally Directed Medical Research Programs
Funding: $ 1,487,973
-
132.
William Breitbart
Individual Meaning-Centered Psychotherapy in Advanced Cancer Patients
National Cancer Institute
Funding: $ 2,115,100
-
133.
Charles Sawyers
Starr Cancer Consortium
Funding: $ 500,000
-
134.
Neal Rosen
Development of Mechanism-based Therapies for the Treatment of Metastatic Melanoma
Starr Cancer Consortium
Funding: $ 802,541
-
135.
Ross Levine
Functional genetic and proteomic analysis of sensitivity and resistance to targeted therapies.
Starr Cancer Consortium
Funding: $ 332,000
-
136.
Ross Levine
Molecular Pathogenesis and Therapy of ET and PMF
National Cancer Institute
Funding: $ 873,630
-
137.
Carma Bylund-Lincoln
Doctor-patient communicaiton about colorectal cancer screening and health disparities
National Cancer Institute
Funding: $ 750,827
-
138.
Valerie Rusch
The Cancer Genome Atlas (TCGA) Project- Biospecimens for Lung Cancer
National Cancer Institute
Funding: $ 38,973
-
139.
-
140.
Gavril Pasternak
Pharmacology of Opioid Receptor Subtypes
National Institute on Drug Abuse
Funding: $ 1,129,535
-
141.
Filippo Giancotti
Mechanism of Merlin-mediated contact inhibition and tumor suppression
National Cancer Institute
Funding: $ 1,319,202
-
142.
Gabriela Chiosis
Small molecule Hsp90 inhibitors in AD treatment
National Institute on Aging
Funding: $ 2,149,802
-
143.
Nancy Kernan
National Marrow Donor Program
Sponsor: Congressionally Directed Medical Research Programs
Funding: $ 32,000
-
144.
Jedd Wolchok
Immunization Against Melanoma Differentiation Antigens
National Cancer Institute
Funding: $ 800,543
-
145.
Marcel Van Den Brink; Malcolm Moore
Radiation Effects Research Foundation
Sponsor: National Institute of Allergy and Infectious Diseases
Funding: $ 822,120
-
146.
Jason Koutcher
MR-PET for a Small Animal Imaging Center
National Cancer Institute
Funding: $ 1,211,567
-
147.
Hedvig Hricak
Molecular Imaging: Training for Oncology
National Cancer Institute
Funding: $ 2,422,672
-
148.
Scott Lowe
Ras Induced Senescence and Tumor Suppression
National Institute on Aging
Funding: $ 585,228
-
149.
Michael Kharas
The Role of the Musashi Family in Hematopoiesis
National Institute of Diabetes & Digestive & Kidney Diseases
Funding: $ 400,678
-
150.
Milan Chheda
Characterization of GEFT as a Novel Glioblastoma Oncogene
National Institute of Neurological Disorders and Stroke
Funding: $ 765,286
-
151.
Howard Scher; Michael Morris; Dana Rathkopf
Coordinating Center Application for Prostate Cancer Research Program Clinical Consortium Award
Congressionally Directed Medical Research Programs
Funding: $ 5,785,727
-
152.
Richard O'Reilly
Primary Immune Deficiency Treatment Consortium
University of California, San Francisco
Sponsor: National Institute of Allergy and Infectious Diseases
Funding: $ 129,798
-
153.
Anna-Katerina Hadjantonakis
Morphogenesis of mammalian gut endoderm
National Institute of Diabetes & Digestive & Kidney Diseases
Funding: $ 893,994
-
154.
Jamie Ostroff
QUEENS CANCER CENTER OF QUEENS HOSPITAL
Sponsor: New York State Department of Health
Funding: $ 61,726
-
155.
Eric Holland; Charles Sawyers
P31K signaling and biology of therapeutic response in brain and prostate tumors
National Cancer Institute
Funding: $ 2,395,918
-
156.
Steven Larson; Jorge Carrasquillo; Mithat Gonen; Jason Lewis; Michael Morris; Neeta Pandit-Taskar
Starr Cancer Consortium
Funding: $ 700,000
-
157.
Ming Li
Starr Cancer Consortium
Funding: $ 400,000
-
158.
-
159.
-
160.
Gary Schwartz
Developing New Strategies for Targeting mTOR and IGF-1R/PI3K/Akt Pathways in Sarcoma
National Cancer Institute
Funding: $ 758,480
-
161.
Kenneth Offit; Larry Norton
Genomic Structural Variation in Cancer Susceptibility
Starr Cancer Consortium
Funding: $ 131,507
-
162.
Clifford Hudis
Johns Hopkins University
Sponsor: Avon Foundation
Funding: $ 85,157
-
163.
Clifford Hudis
Johns Hopkins University
Sponsor: Avon Foundation
Funding: $ 242,345
-
164.
-
165.
Clifford Hudis
Johns Hopkins University
Sponsor: Breast Cancer Research Foundation, The
Funding: $ 415,132
-
166.
Jonine Bernstein
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer
National Cancer Institute
Funding: $ 12,688,305
-
167.
David Scheinberg
Biology of Alpha Particle Immunotherapy
National Cancer Institute
Funding: $ 1,061,513
-
168.
Alexandra Joyner
Engrailed genes and cerebellum morphology, spatial gene expression and circuitry
National Institute of Mental Health
Funding: $ 1,217,750
-
169.
Renier Brentjens
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T Cells
National Cancer Institute
Funding: $ 908,124
-
170.
Hakim Djaballah
Pacific NorthWest Regional Center of Excellence (PNWRCE)
Oregon Health & Science University
Sponsor: National Institute of Allergy and Infectious Diseases
Funding: $ 405,610
-
171.
Filippo Giancotti
Integrin Signaling During Breast Tumorigenesis
National Cancer Institute
Funding: $ 911,285
-
172.
Lorenz Studer; Hakim Djaballah; Viviane Tabar; Mark Tomishima
The Sloan-Kettering Institute Stem Cell Research Facility
NYSTEM Program of New York State Department of Health
Funding: $ 2,338,462
-
173.
Tim Ahles
The CCNY/MSKCC Partnership for Research Training and Outreach
National Cancer Institute
Funding: $ 4,546,069
-
174.
Tim Ahles
The CCNY/MSKCC Partnership for Research Training and Outreach
National Cancer Institute
Funding: $ 4,501,920
-
175.
Tim Ahles
The CCNY/MSKCC Partnership for Research Training and Outreach
National Cancer Institute
Funding: $ 4,681,657
-
176.
Kitai Kim
Hematopoietic potential of histocompatible embryonic stem cell lines
National Heart, Lung, and Blood Institute
Funding: $ 472,417
-
177.
Craig Thompson; Jose Baselga
National Cancer Institute
Funding: $ 40,338,959
-
178.
-
179.
Gikas Mageras
Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver
National Cancer Institute
Funding: $ 1,340,780
-
180.
Song-Hai Shi
Molecular Control of Progenitor Cell Polarity and Cortical Neurogenesis
National Institute on Drug Abuse
Funding: $ 1,109,341
-
181.
Larry Norton
Program Project in Models of Breast Cancer
National Cancer Institute
Funding: $ 7,721,539
-
182.
Gavril Pasternak
Synthesis and pharmacology of novel opiates and their modulatory systems
National Institute on Drug Abuse
Funding: $ 905,150
-
183.
David Spriggs
Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis
National Cancer Institute
Funding: $ 697,431
-
184.
David Solit; Neal Rosen
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
National Cancer Institute
Funding: $ 1,025,050
-
185.
David Spriggs
Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis
National Cancer Institute
Funding: $ 826,783
-
186.
-
187.
-
188.
Denise Correa
Weill Medical College of Cornell University
Sponsor: Leon Levy Foundation
Funding: $ 337,593
-
189.
Katharine Hsu
NK Tolerance and Hematopoietic Cell Transplantation
National Heart, Lung, and Blood Institute
Funding: $ 1,147,750
-
190.
Sergio Giralt
BMT Clinical Trials Network (BMT CTN)
National Marrow Donor Program
Sponsor: National Cancer Institute
Funding: $ 0
-
191.
Alexandra Joyner
Roles of Mouse GLI Genes in Hedgehog Signaling
National Cancer Institute
Funding: $ 1,319,399
-
192.
Clifford Hudis
(Avon): Breast Cancer Research Consortium
Johns Hopkins University
Sponsor: Avon Foundation
Funding: $ 90,910
-
193.
Gavril Pasternak
Biochemical Characterization of Opioid Binding Sites
National Institute on Drug Abuse
Funding: $ 592,376
-
194.
-
195.
Raju Chaganti
Columbia University
Sponsor: Leukemia and Lymphoma Society
Funding: $ 920,000
-
196.
Clifford Hudis
U10/CANCER AND LEUKEMIA GROUP B (CALGB)
Alliance for Clinical Trials in Oncology Foundation
Funding: $ 0
-
197.
Colin Begg
U10/CANCER AND LEUKEMIA GROUP B (CALGB)
Alliance for Clinical Trials in Oncology Foundation
Funding: $ 108,000
*Grants count displayed may not represent all of an Expert's awards. Only awards managed by the Grants & Contracts office are posted.
